India to Brazil: Ondansetron Export Trade Route

The India to Brazil Ondansetron corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $1.8M USD. The route is dominated by ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED, which alone accounts for roughly 78% of all export value, reflecting the consolidated nature of India's ondansetron manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $38.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with ondansetron's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 17.5%, placing it at rank #4 among India's top ondansetron export destinations globally.

On the import side, key buyers of Indian ondansetron in Brazil include SANOFI MEDLEY FARMACEUTICA LTDA, SANOFI MEDLEY FARMACEUTICA LIMITEDA, PRATI, DONADUZZI & CIA LTDA and 5 others. SANOFI MEDLEY FARMACEUTICA LTDA is the single largest importer with 18 shipments valued at $900.6K USD.

India's ondansetron exports to Brazil are driven primarily by a handful of large-scale manufacturers. ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED with 35 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED, ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED , SUN PHARMACEUTICAL INDUSTRIES LTD — together account for 100% of total trade value on this route. The average shipment value of $38.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ondansetron 4mg tabor bl 10 m24 br and ondansetron odt 8mg 10's (ondansetrona cld 8mg 10cps odt) batch no. 2536501 & 2536502, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SANOFI MEDLEY FARMACEUTICA LTDA is the largest importer with 18 shipments worth $900.6K USD — representing 51% of all ondansetron imports from India on this route. A total of 8 buyers are active on this corridor.